Significant Shareholders

Accessing our website tells us you are happy to receive all our cookies. However you can change your cookie settings at any time.

You have clicked on a link that will take you to a third-party website that Alliance Pharmaceuticals plc group (“Alliance”) is not responsible for.

Please read the following disclaimer and click “I agree” to proceed to the third-party website.

By clicking to continue you agree that:You are leaving Alliance`s website.

Alliance:

Is not responsible for the content or accuracy of the third-party website nor endorse or guarantee any services or information they may offer.
Does not represent either the third-party website or you (the visitor) if you enter into an agreement or transaction.
Privacy and security policies do not apply to third-party websites.

Shares in Issue: 530,412,678 1p Ordinary Shares

Last updated: 13th May 2020

Significant Shareholders	Amount	% Holding
Fidelity Management & Research	49,810,760	9.39
John Dawson (beneficial and non-beneficial holdings)	44,212,402	8.30
Slater Investment	42,301,894	7.98
BlackRock Inc	27,451,889	5.18
MVM Life Science Partners LLP	24,760,663	4.70
Polar Capital Holdings	19,663,707	3.71
Investec Group	18,187,402	3.43
GVQ Investment	18,006,489	3.39
Rathbone Investment	17,423,951	3.29
Artemis Investment	17179066	3.24

Shareholdings of Directors & their families	Amount	% Holding
Peter Butterfield	412,461	0.08
Nigel Clifford	180,663	0.04
Andrew Franklin	128,384	0.02
David Cook	102,371	0.02
Richard Jones	15,000	0.00